Toremifene citrate: Additional Phase III data

Additional data from a 2-year, double-blind, U.S. and Mexican Phase III trial in 1,382 patients showed that 80 mg toremifene increased BMD of the hip and lumbar spine after 2 years by 1.6% and 2%, res...